India began commercial exports and sent two million doses of Covishield, developed by AstraZeneca and the University of Oxford, to Brazil on January 22.
Read more here:: Post India Listing
Follow Our Network On LinkedIn: Follow link
Skip to the contentIndia began commercial exports and sent two million doses of Covishield, developed by AstraZeneca and the University of Oxford, to Brazil on January 22.
Read more here:: Post India Listing